Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials

Most academic precision oncology programs have been designed to facilitate enrollment of patients in early clinical trials with matched targeted agents. Over the last decade, major changes were seen both in the targetable molecular alteration landscape and in drug development trends. In this article...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JCO Precis Oncol
Hoofdauteurs: Dienstmann, Rodrigo, Garralda, Elena, Aguilar, Susana, Sala, Gemma, Viaplana, Cristina, Ruiz-Pace, Fiorella, González-Zorelle, Jenifer, Grazia LoGiacco, Deborah, Ogbah, Zighereda, Ramos Masdeu, Laia, Mancuso, Francesco, Fasani, Roberta, Jimenez, Jose, Martinez, Paola, Oaknin, Ana, Saura, Cristina, Oliveira, Mafalda, Balmaña, Judith, Carles, Joan, Macarulla, Teresa, Elez, Elena, Alsina, Maria, Braña, Irene, Felip, Enriqueta, Tabernero, Josep, Rodon, Jordi, Nuciforo, Paolo, Vivancos, Ana
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2020
Onderwerpen:
Special Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446427/
https://ncbi.nlm.nih.gov/pubmed/32923891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00398
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items